Table 2.
Number of lesions visible on the acquired high b-value DWI and the calculated DWI for all targeted lesions and tumor positive lesions for lesion size less than 10mm (Table 2a) and lesion size greater than 10mm (Table 2b). Percentage of lesions visible among all the corresponding lesions in the cell of the table is noted in parentheses.
| b = 1000s/mm2 | b = 2000s/mm2 | |||||
|---|---|---|---|---|---|---|
|
| ||||||
| Acquired | DK | IVIM | Acquired | DK | IVIM | |
| All targets (n = 132) | 61 (46%) | 49 (37%) | 61 (46%) | 85 (64%) | 10 (8%) | 90 (68%) |
| Gleason 6–9 (n = 43) | 22 (51%) | 17 (40%) | 23 (53%) | 36 (84%) | 7 (16%) | 38 (88%) |
| Gleason 6–7 (n = 30) | 14 (47%) | 11 (37%) | 15 (50%) | 27 (90%) | 3 (10%) | 26 (87%) |
| Gleason 8–9 (n = 13) | 8 (62%) | 6 (46%) | 8 (62%) | 9 (69%) | 4 (31%) | 12 (92%) |
| b = 1000s/mm2 | b = 2000s/mm2 | |||||
|---|---|---|---|---|---|---|
|
| ||||||
| Acquired | DK | IVIM | Acquired | DK | IVIM | |
| All targets (n = 107) | 71 (66%) | 65 (61%) | 68 (64%) | 86 (80%) | 30 (28%) | 84 (79%) |
| Gleason 6–9 (n = 47) | 35 (74%) | 34 (72%) | 36 (77%) | 42 (89%) | 22 (47%) | 41 (87%) |
| Gleason 6–7 (n = 30) | 20 (67%) | 20 (67%) | 21 (70%) | 26 (87%) | 13 (43%) | 25 (83%) |
| Gleason 8–9 (n = 17) | 15 (88%) | 14 (82%) | 15 (88%) | 16 (94%) | 9 (53%) | 16 (94%) |